Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Sales | 42,295 | 6,019 | 28,795 | 5,409 | 7,579 |
| Cost of Goods | 4,737 | N/A | N/A | N/A | N/A |
| Gross Profit | 37,558 | 6,019 | 28,795 | 5,409 | 7,579 |
| Operating Expenses | 87,849 | 44,896 | 29,169 | 30,766 | 36,390 |
| Operating Income | -49,554 | -38,877 | -374 | -25,357 | -28,811 |
| Interest Expense | 4,045 | 1,605 | 1,815 | 2,191 | 2,373 |
| Other Income | 257 | 4,898 | 11,577 | 22,219 | -33,740 |
| Pre-tax Income | -53,342 | -35,584 | 9,388 | -5,329 | -64,924 |
| Income Tax | N/A | N/A | N/A | N/A | 101 |
| Net Income Continuous | -53,342 | -35,584 | 9,388 | -5,329 | -65,025 |
| Net Income | $-53,342 | $-35,584 | $9,388 | $-5,329 | $-65,025 |
| EPS Basic Total Ops | -1.63 | -1.66 | 0.61 | -0.44 | -6.14 |
| EPS Basic Continuous Ops | -1.63 | -1.66 | 0.61 | -0.44 | -6.14 |
| EPS Diluted Total Ops | -1.63 | -1.66 | 0.61 | -1.93 | -6.14 |
| EPS Diluted Continuous Ops | -1.63 | -1.66 | 0.61 | -0.41 | -6.14 |
| EPS Diluted Before Non-Recurring Items | -1.64 | -1.66 | 0.61 | -1.90 | -1.60 |
| EBITDA(a) | $-49,409 | $-38,962 | $-418 | $-25,354 | $-28,743 |